Alpha 2.0
Login Register
» Articles » PMID: 30640372

Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment

Overview
Journal JAMA Intern Med
Publisher American Medical Association
Specialty General Medicine
Date 2019 Jan 15
PMID 30640372
Citations 6
Authors
Amer Raheemullah
Anna Lembke
Affiliations
Soon will be listed here.
Citing Articles

Efficacy of transdermal buprenorphine patch for managing withdrawal symptoms in patients with cancer physically dependent on prescription opioids.

Kang J, Lee K, Huh S, Shin S, Kim I, Hwang I Oncologist. 2024; 29(11):e1593-e1603.

PMID: 39028339 PMC: 11546621. DOI: 10.1093/oncolo/oyae176.

Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis.

K K A, E J M, D M S Addict Sci Clin Pract. 2022; 17(1):55.

PMID: 36195895 PMC: 9531395. DOI: 10.1186/s13722-022-00336-z.

Initiation of opioid agonist treatment and subsequent substance use and other patterns among adolescents and young adults in Vancouver, Canada.

Pilarinos A, Fast D, Nosova E, Kwa Y, Joe R, Buxton J Drug Alcohol Depend. 2022; 235:109441.

PMID: 35427979 PMC: 9872979. DOI: 10.1016/j.drugalcdep.2022.109441.

Substance Use/Dependence in Psychiatric Emergency Setting Leading to Hospitalization: Predictors of Continuity of Care.

Maremmani A, Aglietti M, Intaschi G, Bacciardi S Int J Environ Res Public Health. 2022; 19(2).

PMID: 35055582 PMC: 8775711. DOI: 10.3390/ijerph19020760.

Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review.

Adams K, Machnicz M, Sobieraj D Addict Sci Clin Pract. 2021; 16(1):36.

PMID: 34103087 PMC: 8186092. DOI: 10.1186/s13722-021-00244-8.